(Q31422765)

2 July 2017

Pramipexole-induced somnolence and episodes of daytime sleep (English)

1 reference

2 July 2017

Hauser RA

1

1 reference

2 July 2017

Gauger L

series ordinal

2

1 reference

2 July 2017

Anderson WM

series ordinal

3

1 reference

2 July 2017

Zesiewicz TA

series ordinal

4

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

2 July 2017

1 reference

2 July 2017

15

1 reference

2 July 2017

658-663

1 reference

2 July 2017

4

1 reference

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.

2 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Sertraline for the treatment of depression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200007%2915%3A4%3C658%3A%3AAID-MDS1009%3E3.0.CO%3B2-N

10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference